Vir Biotechnology (VIR) Goodwill (2018 - 2026)

Vir Biotechnology has reported Goodwill for 9 years, with the latest figure at $16.9 million in Q1 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $16.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $16.9 million, changed 0.0% from the prior year.
• Goodwill was little changed at $16.9 million in Q1 2026 per VIR's latest filing, from $16.9 million in the prior quarter.
• Over five years, Goodwill peaked at $16.9 million in Q3 2024 and troughed at $16.9 million in Q1 2022.
• A 5-year average of $16.9 million and a median of $16.9 million in 2022 frame the typical range for Goodwill.
• The sharpest annual moves came in 2024 and 2025: Goodwill increased 0.01% in 2024, then slipped 0.01% in 2025.
• Over 5 years, Goodwill stood at $16.9 million in 2022, then changed by 0.0% to $16.9 million in 2023, then changed by 0.0% to $16.9 million in 2024, then changed by 0.0% to $16.9 million in 2025, then changed by 0.0% to $16.9 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $16.9 million, $16.9 million, and $16.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.